Veracyte - Optima试验显示Prosigna检测可识别高风险乳腺癌患者,使其免于化疗

美股速递
May 30

Veracyte公司宣布,其Optima试验结果表明,Prosigna检测能够有效识别出高风险乳腺癌患者中那些可以安全避免化疗的个体。这一发现为精准医疗在乳腺癌治疗领域的应用提供了有力支持,有望帮助更多患者减少不必要的治疗负担。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10